122 related articles for article (PubMed ID: 30900719)
1. A self-assembled DNA-nanoparticle with a targeting peptide for hypoxia-inducible gene therapy of ischemic stroke.
Oh J; Lee J; Piao C; Jeong JH; Lee M
Biomater Sci; 2019 Apr; 7(5):2174-2190. PubMed ID: 30900719
[TBL] [Abstract][Full Text] [Related]
2. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.
Choi M; Oh J; Rhim T; Lee M
Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961
[TBL] [Abstract][Full Text] [Related]
3. Deoxycholic Acid-Conjugated Polyethylenimine for Delivery of Heme Oxygenase-1 Gene in Rat Ischemic Stroke Model.
Oh J; Lee MS; Jeong JH; Lee M
J Pharm Sci; 2017 Dec; 106(12):3524-3532. PubMed ID: 28780392
[TBL] [Abstract][Full Text] [Related]
4. Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone.
Hyun H; Lee J; Hwang DW; Kim S; Hyun DK; Choi JS; Lee JK; Lee M
Biomaterials; 2011 Jan; 32(1):306-15. PubMed ID: 20888632
[TBL] [Abstract][Full Text] [Related]
5. Messenger RNA/polymeric carrier nanoparticles for delivery of heme oxygenase-1 gene in the post-ischemic brain.
Oh J; Kim SM; Lee EH; Kim M; Lee Y; Ko SH; Jeong JH; Park CH; Lee M
Biomater Sci; 2020 Jun; 8(11):3063-3071. PubMed ID: 32348398
[TBL] [Abstract][Full Text] [Related]
6. Delivery of self-replicating messenger RNA into the brain for the treatment of ischemic stroke.
Kim M; Oh J; Lee Y; Lee EH; Ko SH; Jeong JH; Park CH; Lee M
J Control Release; 2022 Oct; 350():471-485. PubMed ID: 36041589
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone-loaded peptide micelles for delivery of the heme oxygenase-1 gene to ischemic brain.
Lee J; Hyun H; Kim J; Ryu JH; Kim HA; Park JH; Lee M
J Control Release; 2012 Feb; 158(1):131-8. PubMed ID: 22100389
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model.
Kim M; Lee Y; Lee M
Nanoscale; 2021 Sep; 13(33):14166-14178. PubMed ID: 34477698
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic Preconditioning Augments the Therapeutic Efficacy of Bone Marrow Stromal Cells in a Rat Ischemic Stroke Model.
Chen J; Yang Y; Shen L; Ding W; Chen X; Wu E; Cai K; Wang G
Cell Mol Neurobiol; 2017 Aug; 37(6):1115-1129. PubMed ID: 27858286
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of a reducible poly (oligo-D-arginine) carrier with the heme oxygenase-1 gene in the treatment of hypoxic-ischemic brain injury.
Hyun H; Won YW; Kim KM; Lee J; Lee M; Kim YH
Biomaterials; 2010 Dec; 31(34):9128-34. PubMed ID: 20828810
[TBL] [Abstract][Full Text] [Related]
11. Combined gene therapy with hypoxia-inducible factor-1α and heme oxygenase-1 for therapeutic angiogenesis.
Bhang SH; Kim JH; Yang HS; La WG; Lee TJ; Kim GH; Kim HA; Lee M; Kim BS
Tissue Eng Part A; 2011 Apr; 17(7-8):915-26. PubMed ID: 20979535
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone-Conjugated Polyamidoamine Dendrimer for Delivery of the Heme Oxygenase-1 Gene into the Ischemic Brain.
Jeon P; Choi M; Oh J; Lee M
Macromol Biosci; 2015 Jul; 15(7):1021-8. PubMed ID: 26033925
[TBL] [Abstract][Full Text] [Related]
13. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
[TBL] [Abstract][Full Text] [Related]
14. A ternary-complex of a suicide gene, a RAGE-binding peptide, and polyethylenimine as a gene delivery system with anti-tumor and anti-angiogenic dual effects in glioblastoma.
Choi E; Oh J; Lee D; Lee J; Tan X; Kim M; Kim G; Piao C; Lee M
J Control Release; 2018 Jun; 279():40-52. PubMed ID: 29660374
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model.
Demougeot C; Van Hoecke M; Bertrand N; Prigent-Tessier A; Mossiat C; Beley A; Marie C
J Pharmacol Exp Ther; 2004 Dec; 311(3):1080-7. PubMed ID: 15280435
[TBL] [Abstract][Full Text] [Related]
16. A hypoxia-inducible vigilant vector system for activating therapeutic genes in ischemia.
Tang YL; Tang Y; Zhang YC; Agarwal A; Kasahara H; Qian K; Shen L; Phillips MI
Gene Ther; 2005 Aug; 12(15):1163-70. PubMed ID: 15800659
[TBL] [Abstract][Full Text] [Related]
17. Brain gene delivery using histidine and arginine-modified dendrimers for ischemic stroke therapy.
Lee Y; Lee J; Kim M; Kim G; Choi JS; Lee M
J Control Release; 2021 Feb; 330():907-919. PubMed ID: 33152393
[TBL] [Abstract][Full Text] [Related]
18. N-Myc Downstream-Regulated Gene 2 (Ndrg2) Is Involved in Ischemia-Hypoxia-Induced Astrocyte Apoptosis: a Novel Target for Stroke Therapy.
Ma YL; Zhang LX; Liu GL; Fan Y; Peng Y; Hou WG
Mol Neurobiol; 2017 Jul; 54(5):3286-3299. PubMed ID: 27154863
[TBL] [Abstract][Full Text] [Related]
19. Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system.
Tang YL; Tang Y; Zhang YC; Qian K; Shen L; Phillips MI
Hypertension; 2004 Apr; 43(4):746-51. PubMed ID: 14981066
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow stromal cells inhibits HMGB1-mediated inflammation after stroke in type 2 diabetic rats.
Hu J; Liu B; Zhao Q; Jin P; Hua F; Zhang Z; Liu Y; Zan K; Cui G; Ye X
Neuroscience; 2016 Jun; 324():11-9. PubMed ID: 26946264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
